Skip to Content

Rhoen Klinikum AG RHKJF

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.

Salzburger Leite 1
Bad Neustadt a. d. Saale, 97616, Germany
T +49 9771650
Sector Healthcare
Industry Medical Care Facilities
Most Recent Earnings Sep 30, 2020
Fiscal Year End Dec 31, 2019
Stock Type
Employees 18,242